iShares Small Cap 600

Edgestream Partners L.P. reduced stake in Brink's Inc.

SiTime insider sells stock

Corcept Therapeutics Inc Executives Sean Maduck Sold $1.6 Million in Stocks

SiTime CEO Rajesh Vashist Reports Sale of Company Common Stock

SiTime is said in talks to acquire Renesas’s timing division

MegaChips Corp Sells SITIME Shares to Book 1.5 Billion Yen Special Gain

InterDigital Director Sells Common Stock

Federated Signal expects sales of $2.12 billion to $2.16 billion for fiscal 2023

Federated Signal Completes Acquisition of NewWay Truck Company

SiTime Corporation Official Disposes of Company Common Stock

Citigroup Research Upgrades Brinker International Stock Rating

SiTime Corp's VP Sells Shares to Cover Option Exercise Costs and/or Tax Obligations

SiTime Corp CFO Elizabeth Howe Sells Stock

William Blair Analyst Maintains Buy Rating on InterDigital

MegaChips Disposes of SiTime Corporation Common Stock

Moog released FY2025 Q4 earnings during market hours on November 21 (EST), with actual revenue of USD 1.044 B (forecast USD 963.09 M) and actual EPS of USD 2.0799 (forecast USD 2.215)

Moog released FY2025 annual earnings on November 21 During-Market EST, actual revenue USD 3.861 B (forecast USD 3.779 B), actual EPS USD 7.3299 (forecast USD 7.72)

Empowered Funds LLC Reduces Holdings in Brink's Inc.

Daikon Industries Q3 2026 Earnings Beat Expectations

Dycom Industries released FY2026 Q3 earnings on November 19 Pre-Market EST, actual revenue USD 1.452 B (forecast USD 1.408 B), actual EPS USD 3.6299 (forecast USD 3.2018)

SEVEN HILLS RLTY TR COM USD0.001 (S/R 04/12/2025)

SMX Security Matters

Polyrizon

Picard Medical

Synchronoss Tech

PharmaCyte Biotech

Q/C Tech

Rich Sparkle

Hoyne Bancorp

Tradr 2X Long ASTS Daily ETF

Edgestream Partners L.P. reduced its stake in Brinker International, Inc. by 46.6% in Q2, owning 13,711 shares worth $2.47 million. Brinker reported Q2 earnings of $1.93 per share, beating estimates, with revenue up 18.5% year-over-year. Analysts have mixed ratings on the stock, with target prices ranging from $135 to $210. COO Douglas N. Comings sold 16,000 shares, decreasing his position by 55.27%.

Market Beat

Brinker

Edgestream Partners L.P. Cuts Stake in Brinker International, Inc. $EAT

IDCC

InterDigital Inc. has declared a quarterly cash dividend of $0.70 per share on its common stock.

Reuters

InterDigital Comm

InterDigital Inc. declares $0.70 per share quarterly cash dividend

MOG.A

John Scannell, Chairman of Moog Inc, filed a Form 144 with the SEC to sell 9,000 shares of restricted stock through Merrill Lynch & Co Inc. The filing allows the sale within 90 days. This is part of insider trading regulations requiring such filings before selling restricted securities.

Moog

Chmn Scannell Files To Sell 9,000 Of Moog Inc [MOG.A]

CORT

Corcept Therapeutics Insider Sold Shares Worth $1,590,490, According to a Recent SEC Filing

marketscreener

Corcept Therap

Corcept Therapeutics Insider Sold Shares Worth $1,590,490, According to a Recent SEC Filing

PTCT

PTC Therapeutics CEO Matthew B. Klein sold 3,428 shares worth $271,051 on December 3, 2025. The company has seen significant stock activity due to strong Q3 earnings and the launch of Sephience. RBC Capital downgraded the stock, while Goldman Sachs and TD Cowen raised their price targets. Despite challenges, the earnings call was positive. TipRanks’ AI Analyst rates PTCT as Outperform, citing strong technical indicators and favorable valuation.

Tip Ranks

PTC Therap

PTC Therapeutics CEO Makes Significant Stock Sale!

Officer Sean Maduck of Corcept Therapeutics Inc sold 20,000 shares worth $1.6 million, as disclosed in a Form 4 filed with the SEC. The sale was part of a prearranged trading plan (10b5-1). Ending holdings are 117,896 shares. The Washington Service offers insider trading analysis and data services.

Officer Maduck Sells 20,000 ($1.6M) Of Corcept Therapeutics Inc [CORT]

Officer Lyon Joseph Douglas of Corcept Therapeutics Inc sold 5,000 shares for $397,632 as part of a prearranged trading plan. The transaction was disclosed in a Form 4 filed with the SEC. The officer also exercised options and surrendered shares to cover costs and tax liabilities, ending with 10,523 shares directly held.

Officer Lyon Sells 5,000 ($397.6K) Of Corcept Therapeutics Inc [CORT]

Corcept Therapeutics Inc's CFO, Mokari Atabak, surrendered 118 shares back to the company on December 2, 2025, to cover option exercise costs and tax liabilities. The shares were valued at $9,414, with a price of $79.78 per share. Mokari's direct holdings now total 14,559 shares.

CFO Mokari Surrenders 118 Of Corcept Therapeutics Inc [CORT]

Guyer William Officer of Corcept Therapeutics Inc [CORT] filed a Form 4/A on December 3, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:DateTransactionSharesPriceValue11/17/25Gift5,287$0.00N/A11/25/25Sale4,500$80.90$364,070Ending Holdings: 787 (0 - Direct, 787 - Indirect) For a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.

Officer Guyer Sells 4,500 ($364.1K) Of Corcept Therapeutics Inc [CORT]-Amended

Robb Gary Charles, an officer of Corcept Therapeutics Inc, surrendered 148 shares back to the company to cover option exercise costs and tax liabilities. The transaction was filed with the SEC on December 3, 2025, with the shares valued at $11,807. His ending holdings are 37,052 shares, split between direct and indirect ownership.

Officer Robb Surrenders 148 Of Corcept Therapeutics Inc [CORT]

Joseph K. Belanoff, CEO of Corcept Therapeutics, reported the disposal of common shares of the company. The full filing is available via EDGAR, the U.S. SEC's system. This information is for informational purposes only and not financial advice.

Corcept Therapeutics CEO Joseph K. Belanoff Reports Disposal of Common Shares

CEO Matthew B. Klein of PTC Therapeutics Inc. filed a Form 4 with the SEC, disclosing changes in ownership. On December 1, 2025, he exercised 7,812 shares at $0.00, and on December 2, 2025, he surrendered 3,428 shares at $79.07, valued at $271,052, under a prearranged trading plan (10b5-1). Ending holdings are 349,964 shares directly.

CEO Klein Acquires 4,384 Of PTC Therapeutics Inc [PTCT]

MOG.B

Moog Inc. (NYSE:MOG.B) saw its stock price rise by 9.9% during mid-day trading, reaching as high as $220.00 and last trading at $236.3340. Despite the price increase, trading volume was down 23% from the average. Moog has a market cap of $7.42 billion and a PE ratio of 35.53. Analysts currently have a Hold rating on Moog, suggesting other stocks may be better investments.

Moog-B

Moog (NYSE:MOG.B) Trading 9.9% Higher   - Time to Buy?

Emma Reeve, Director of PTC Therapeutics Inc, filed a Form 144 with the SEC on December 3, 2025, to sell 733 shares of restricted securities through Fidelity Brokerage Services under a prearranged trading plan (10b5-1).

Dir Reeve Files To Sell 733 Of PTC Therapeutics Inc [PTCT]

CIFR

Amid market volatility, TipRanks' Technical Analysis Screener identifies three 'Strong Buy' stocks: Corcept Therapeutics (CORT), Axis Capital (AXS), and Cipher Mining (CIFR). These stocks show bullish momentum and potential short- to mid-term upside, supported by strong Wall Street analyst ratings. TipRanks offers a Cyber Monday sale with 60% off its Premium service for data-backed insights and research tools.

Cipher Mining

Axis Capital

3 'Strong Buy' Stocks Backed by Technical Analysis